Gynecologic health care for the adolescent solid organ transplant recipient

Pediatric Transplantation

Volumn 9, Issue 3, 2005, Pages 346-356

  Sucato, Gina S ^a   Murray, Pamela J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent; Contraception; Immunocompromised host; Menstruation; Organ transplantation; Puberty; Sexual behavior; Sexually transmitted diseases

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DIURETIC AGENT; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; GESTAGEN; HYPOCHOLESTEROLEMIC AGENT; IMMUNOSUPPRESSIVE AGENT; MEDROXYPROGESTERONE ACETATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADOLESCENCE; ADOLESCENT; CARDIOVASCULAR DISEASE; CONDOM; CONFERENCE PAPER; CONTRACEPTION; DIABETES MELLITUS; DIARRHEA; DRUG EXCRETION; DRUG METABOLISM; EMERGENCY CONTRACEPTION; FEMALE; FERTILITY; GYNECOLOGY; HEADACHE; HEALTH CARE; HEALTH CARE NEED; HORMONAL CONTRACEPTION; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIVER TOXICITY; MENSTRUATION; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; SEXUALITY; SOCIAL ASPECT; THROMBOEMBOLISM; VOMITING; WEIGHT GAIN;

ADOLESCENT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; CONTRACEPTIVES, POSTCOITAL; DRUG INTERACTIONS; DYSMENORRHEA; FEMALE; GYNECOLOGY; HUMANS; IMMUNOCOMPROMISED HOST; INTRAUTERINE DEVICES; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUATION; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PUBERTY; REPRODUCTIVE HEALTH SERVICES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; VAGINAL SMEARS;

EID: 20344371506     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00266.x     Document Type: Conference Paper

References (68)

1. VAN DIEMEN-STEENVOORDE R, DONCKERWOLCKE RA, BRACKEL H, WOLFF ED, DE JONG MC. Growth and sexual maturation in children after kidney transplantation. J Pediatr 1987: 110: 351-356.
2. VINER RM, FORTON JT, COLE TJ, CLARK IH, NOBLE-JAMIESON G, BARNES ND. Growth of long-term survivors of liver transplantation. Arch Dis Child 1999: 80: 235-240.
3. DE BROUX E, HUOT CH, CHARTRAND S, VOBECKY S, CHARTRAND C. Growth and pubertal development following pediatric heart transplantation: a 15-year experience at Ste-Justine Hospital. J Heart Lung Transplant 2000: 19: 825-833.
4. LAIFER SA, GUIDO RS. Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc 1995: 70: 388-394.
5. MASS K, QUINT EH, PUNCH MR, MERION RM. Gynecological and reproductive function after liver transplantation. Transplantation 1996: 62: 476-479.
6. KIM LH, CHUN CJ, KANG DM, KWAK J. Kidney transplantation and menstrual changes. Transplant Proc 1998: 30: 3057-3059.
7. PHOCAS I, SARANDAKOU A, KASSANOS D, RIZOS D, TSERKEZIS G, KOUTSIKOS D. Hormonal and ultrasound characteristics of menstrual function during chronic hemodialysis and after successful renal transplantation. Int J Gynaecol Obstet 1992: 37: 19-28.
8. FERRARIS JR, DOMENE HM, ESCOBAR ME, CALETTI MG, RAMIREZ JA, RIVAROLA MA. Hormonal profile in pubertal females with chronic renal failure: before and under haemodialysis and after renal transplantation. Acta Endocrinol (Copenh) 1987: 115: 289-296.
9. BIERMAN M, NOLAN GH. Menstrual function and renal transplantation. Obstet Gynecol 1977: 49: 186-189.
10. CUNDY TF, O'GRADY JG, WILLIAMS R. Recovery of menstruation and pregnancy after liver transplantation. Gut 1990: 31: 337-338.
11. DE KONING ND, HAAGSMA EB. Normalization of menstrual pattern after liver transplantation: consequences for contraception. Digestion 1990: 46: 239-241.
12. NICHOLAS SL, RULIN MC. Acute vaginal bleeding in women undergoing liver transplantation. Am J Obstet Gynecol 1994: 170: 733-736.
13. VALENCIA LS, CROMER BA. Sexual activity and other high-risk behaviors in adolescents with chronic illness: a review. J Pediatr Adolesc Gynecol 2000: 13: 53-64.
14. MELZER SM, LEADBEATER B, REISMAN L, JAFFE LR, LIEBERMAN KV. Characteristics of social networks in adolescents with end-stage renal disease treated with renal transplantation. J Adolesc Health Care 1989: 10: 308-312.
15. HENNING P, TOMLINSON L, RIGDEN SP, HAYCOCK GB, CHANTLER C. Long term outcome of treatment of end stage renal failure. Arch Dis Child 1988: 63: 35-40.
16. GHAHRAMANI N, BEHZADI A, GHOLAMI S, et al. Postrenal transplant improvement of sexual function. Transplant Proc 1999: 31: 3144.
17. CUPPLES SA. Cardiac transplantation in women. Crit Care Nurs Clin North Am 1997: 9: 521-533.
18. O'DONNELL D. Contraception in the female transplant recipient. Dial Transplant 1986: 15: 610-612.
19. LAIFER SA, DARBY MJ, SCANTLEBURY VP, HARGER JH, CARITIS SN. Pregnancy and liver transplantation. Obstet Gynecol 1990: 76: 1083-1088.
20. RIELY CA. Contraception and pregnancy after liver transplantation. Liver Transpl 2001: 7: S74-S76.
21. BRITTO MT, ROSENTHAL SL, TAYLOR J, PASSO MH. Improving rheumatologists' screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med 2000: 154: 478-483.
22. SMITH S. Legal Issues in Treating Minors. In: SANFILIPPO J, MURAM D, DEWHURST J, LEE P, eds. Pediatric and Adolescent Gynecology. Philadelphia: WB Saunders Company, 2001: pp: 513-526.
23. CREININ MD, LISMAN R, STRICKLER RC. Screening for factor V Leiden mutation before prescribing combination oral contraceptives. Fertil Steril 1999: 72: 646-651.
24. KOSSOY LR, HERBERT CM III, WENTZ AC. Management of heart transplant recipients: guidelines for the obstetrician-gynecologist. Am J Obstet Gynecol 1988: 159: 490-499.
25. HATCHER R, GUILLEBAUD J. The pill: combined oral contraceptives. In: HATCHER R, TRUSSELL J, STEWART F, CATES W, STEWART G, GUEST F, KOWAL D, eds. Contraceptive Technology. New York: Ardent Media, 1998: pp: 405-466.
26. FAIGLE J, SCHENKEL L. Pharmacokinetics of estrogens and progestogens. In: FRASER I, JANSEN R, LOBO R, WHITEHEAD M, eds. Estrogens and Progestogens in Clinical Practice. London: Churchill Livingstone, pp: 1998: 273-294.
27. GOLDZIEHER J. Effects on other tissues. In: FRASER I, JANSEN R, LOBO R, WHITEHEAD M, eds. Estrogens and Progestogens in Clinical Practice. London: Churchill Livingstone, pp: 1998: 825-829.
28. CONNELL E. Clinical aspects of oral contraception. In: FRASER I, JANSEN R, LOBO R, WHITEHEAD M, eds. Estrogens and Progestogens in Clinical Practice. London: Churchill Livingstone, 1998: pp: 555-577.
29. DOURAKIS SP, TOLIS G. Sex hormonal preparations and the liver. Eur J Contracept Reprod Health Care 1998: 3: 7-16.
30. BLUMENFELD Z, ENAT R, BRANDES JM, BARUCH Y. Gonadotropin-releasing hormone analogues for dysfunctional bleeding in women after liver transplantation: a new application. Fertil Steril 1992: 57: 1121-1123.
31. LONGCOPE C. Metabolism of estrogens and progestogens. In: FRASER I, JANSEN R, LOBO R, WHITEHEAD M, eds. Estrogens and Progestogens in Clinical Practice. London: Churchill Livingstone, 1998: pp: 89-94.
32. DERAY G, LE HOANG P, CACOUB P, ASSOGBA U, GRIPPON P, BAUMELOU A. Oral contraceptive interaction with cyclosporin. Lancet 1987: 1: 158-159.
33. SUCATO G, MURRAY P. Gynecologic issues of the adolescent female solid organ transplant recipient. Pediatr Clin North Am 2003: 50: 1421-1542.
34. BUSH WW. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. AACN Clin Issues 1999: 10: 253-269.
35. GASTON RS. Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis 2001: 38: S25-S35.
36. GUSTAVSON LE, LEGLER UF, BENET LZ. Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens. J Clin Endocrinol Metab 1986: 62: 234-237.
37. SEIDEGARD J, SIMONSSON M, EDSBACKER S. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol. Clin Pharmacol Ther 2000: 67: 373-381.
38. MUNOZ SJ. Long-term management of the liver transplant recipient. Med Clin North Am 1996: 80: 1103-1120.
39. CUPPLES S. Resources for patients. Transplant medications - Part 1: An overview. Prog Transplant 2002: 12: 71-72.
40. DICKINSON BD, ALTMAN RD, NIELSEN NH, STERLING ML. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001: 98: 853-860.
41. McCANN MF, POTTER LS. Progestin-only oral contraception: a comprehensive review. Contraception 1994: 50: S1-195.
42. SCHOLES D, LACROIX AZ, ICHIKAWA LE, BARLOW WE, OTT SM. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002: 13: 581-587.
43. BRAITH RW, HOWARD C, FRICKER FJ, MITCHELL M, EDWARDS DG. Glucocorticoid-induced osteopenia in adolescent heart transplant recipients. J Heart Lung Transplant 2000: 19: 840-845.
44. CHESNEY RW, ROSE PG, MAZESS RB. Persistence of diminished bone mineral content following renal transplantation in childhood. Pediatrics 1984: 73: 459-466.
45. BOOT AM, NAUTA J, HOKKEN-KOELEGA AC, POLS HA, DE RIDDER MA, DE MUINCK KEIZER-SCHRAMA SM. Renal transplantation and osteoporosis. Arch Dis Child 1995: 72: 502-506.
46. HATCHER R. Depo-Provera, Norplant, and progestin-only pills (Minipills). In: HATCHER R, TRUSSELL J, STEWART F, GATES W, STEWART G, GUEST F, KOWAL D, eds. Contraceptive Technology. New York: Ardent Media, 1998: pp: 467-510.
47. NELSON AL. The intrauterine contraceptive device. Obstet Gynecol Clin North Am 2000: 27: 723-740.
48. DARNEY PD. Time to pardon the IUD? N Engl J Med 2001: 345: 608-610.
49. LEE NC, RUBIN GL, BORUCKI R. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study. Obstet Gynecol 1988: 72: 1-6.
50. HUBACHER D, LARA-RICALDE R, TAYLOR DJ, GUERRA-INFANTE F, GUZMAN-RODRIGUEZ R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001: 345: 561-567.
51. KRONMAL RA, WHITNEY CW, MUMFORD SD. The intrauterine device and pelvic inflammatory disease: the Women's Health Study reanalyzed. J Clin Epidemiol 1991: 44: 109-122.
52. STEWART G. Intrauterine devices. In: HATCHER R, TRUSSELL J, STEWART F, GATES W, STEWART G, GUEST F, KOWAL D, eds. Contraceptive Technology. New York: Ardent Media, 1998: pp: 545-588.
53. ZERNER J, DOIL KL, DREWRY J, LEEBER DA. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 1981: 26: 99-102.
54. MORRISON CS, SEKADDE-KIGONDU C, SINEI SK, WEINER DH, KWOK C, KOKONYA D. Is the intrauterine device appropriate contraception for HIV-1-infected women? BJOG 2001: 108: 784-790.
55. SINEI SK, MORRISON CS, SEKADDE-KIGONDU C, ALLEN M, KOKONYA D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998: 351: 1238-1241.
56. Fu H, DARROCH JE, HAAS T, RANJIT N. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Farn Plann Perspect 1999: 31: 56-63.
57. RODRIGUES I, GROU F, JOLY J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol 2001: 184: 531-537.
58. GRIMES DA, RAYMOND EG. Emergency contraception. Ann Intern Med 2002: 137: 180-189.
59. Task Force On Postovulatory Methods Of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998: 352: 428-433.
60. GREEN M, MICHAELS MG. Infectious complications of solid-organ transplantation in children. Adv Pediatr Infect Dis 1992: 7: 181-204.
61. EL-KHOURY J, STIKKELBROECK MM, GOODMAN A, RUBIN RH, COSIMI AB, FISHMAN JA. Postmenopausal tubo-ovarian abscess due to Pseudomonas aeruginosa in a renal transplant patient: a case report and review of the literature. Transplantation 2001: 72: 1241-1244.
62. KIM SW, NAH MY, YEUM CH, et al. Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient. J Infect 2001: 42: 215-217.
63. STANBERRY LR, SPRUANCE SL, CUNNINGHAM AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002: 347: 1652-1661.
64. KOUTSKY LA, AULT KA, WHEELER CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002: 347: 1645-1651.
65. BROWN MR, NOFFSINGER A, FIRST MR, PENN I, HUSSEINZADEH N. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol 2000: 79: 220-224.
66. SILLMAN FH, SENTOVICH S, SHAFFER D. Ano-genital neoplasia in renal transplant patients. Ann Transplant 1997: 2: 59-66.
67. OZSARAN AA, ATES T, DIKMEN Y, et al. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol 1999: 20: 127-130.
68. ZELDIN GA, MAYGERS J, KLEIN A, THULUVATH PJ. Vaccination, screening for malignancy, and health maintenance of the liver transplant recipient. J Clin Gastroenterol 2001: 32: 148-150.